PharmTech Europe at CPhI - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PharmTech Europe at CPhI

On October 9˜11, 2012, more than 29000 people from over 140 countries are expected to gather at the Feria de Madrid in Spain for CPhI Worldwide 2012 to network, discuss industry trends and hopefully forge new partnerships. This will mark the 23rd edition of this prestigious industry event.

This year, the majority of the PTE team will be attending the show in Mandrid at booth 10A23. You are more than welcome to visit us to let us know what's happening in your corner of the market, or to tell us about something exciting you've seen.

We will be active online during the show, providing daily blogs and feeding important news through our twitter account. If you're not already a follower, and especially if you're not able to attend the show but want to be kept up-to-date, then head to http://PharmTech.com/twitter to join us.

To receive our special CPhI eshow daily and our regular e-newsletter, subscribe here.

CPhI news

What do You Think of CPhI so Far?

Great Expectations for CPhI Worldwide 2012

Start your CPhI Experience with Pre-Connect

Get to Know Madrid

CPhI Worldwide 2012 and Pharma Awards

Sharing Great Innovations at CPhI

Breaking Visitor Records Year on Year

CPhI Takes Centre Stage in Madrid

Strategies for Effective Biologics Outsourcing Examined at CPhI

CPhI Pharma Awards Finalists Announced

CPhI Prepares for India

Changing Industry Models at Work at CPhI

Start your CPhI Experience with Pre-Connect

Useful information

Visitor Registration

Plan Your Stay

Pre-Conference Information

Event Website

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
Click here